TXG 10x Genomics, Inc.

NASDAQ
$57.38

10x Genomics, Inc. (TXG) is expected to report earnings on February 4, 2027, after the market close. The consensus earnings estimate is a loss of $0.20 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -0.9% since its last earnings release on November 5, 2026.

10x Genomics Beat Expectations, Raises Guidance
Thursday, November 5, 2026 · 4:05 PM ET
Earnings Date
4th Quarter, Dec 2026
Feb 4
Thursday · 4:05 PM ET
Earnings Whisper
-
vs ($0.20)
Rev est $170.97M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $59.29

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About 10x Genomics, Inc.

10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health.

Sector

Healthcare

Industry

Medical Instruments/Supply

Charts powered in part by Lightweight Charts™ by TradingView.